GSK (GSK) said Thursday it will stop setting diversity targets, citing US legal concerns amid President Donald Trump's executive orders rolling back federal diversity, equity, and inclusion programs.

The drugmaker said it has largely met past goals for improving ethnic and gender diversity in leadership.

GSK reaffirmed it is committed to an inclusive workplace but added that it will no longer pursue "aspirational targets" for leadership and supplier diversity.

"We expect to make changes in several areas related to inclusion, including no longer setting leadership aspirations," the company said in its annual report.

GSK shares were edging 0.2% lower in recent trading.

Price: 37.31, Change: -0.09, Percent Change: -0.24